| | Identification | Back Directory |  | [Name] 
 Bicyclo[1.1.1]pentane-1-carboxylic acid, 3-[1-[[[1-(2-benzofuranylmethyl)-1H-indol-7-yl]carbonyl]amino]cyclopropyl]-
 |  | [CAS] 
 2455480-28-9
 |  | [Synonyms] 
 KF-0210
 EP4-IN-1
 Bicyclo[1.1.1]pentane-1-carboxylic acid, 3-[1-[[[1-(2-benzofuranylmethyl)-1H-indol-7-yl]carbonyl]amino]cyclopropyl]-
 |  | [Molecular Formula] 
 C27H24N2O4
 |  | [MOL File] 
 2455480-28-9.mol
 |  | [Molecular Weight] 
 440.49
 | 
 | Chemical Properties | Back Directory |  | [Boiling point ] 
 734.2±60.0 °C(Predicted)
 |  | [density ] 
 1.48±0.1 g/cm3(Predicted)
 |  | [form ] 
 Solid
 |  | [pka] 
 4.97±0.40(Predicted)
 |  | [color ] 
 White to light yellow
 | 
 | Hazard Information | Back Directory |  | [Uses] 
 EP4-IN-1 is a potent prostanoid EP4 receptor inhibitor. EP4-IN-1 is extracted from patent WO2023025270 (example 1), and exhibits prospect  in tumor immunity and anti-inflammatory analgesia research[1].
 |  | [IC 50] 
 EP4
 |  | [References] 
 [1] Deng qi yuan,et al.  Solid form of indole compound, preparation method therefor and use thereof. Patent WO2023025270A1.
 | 
 |  |